RxSight (RXST) EBT (2020 - 2026)

RxSight (RXST) has reported EBT for 7 consecutive years, with -$12.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 2.17% year-over-year to -$12.0 million; the trailing twelve-month figure through Jun 2026 stood at -$46.8 million (down 45.57% YoY), and the FY2025 full-year result was -$38.9 million, down 41.86% from the prior year.
• EBT improved to -$12.0 million in Q2 2026 per RXST's latest filing, from -$15.9 million in the prior quarter.
• Across five years, EBT topped out at -$5.9 million in Q4 2024 and bottomed at -$17.6 million in Q1 2022.
• Historically, EBT has averaged -$11.6 million across 5 years, with a median of -$11.9 million in 2025.
• The sharpest annual moves came in 2022 and 2024: EBT slumped 158.78% in 2022, then surged 56.0% in 2024.
• Over 5 years, EBT stood at -$15.6 million in 2022, then surged by 41.08% to -$9.2 million in 2023, then soared by 35.56% to -$5.9 million in 2024, then tumbled by 54.33% to -$9.1 million in 2025, then plunged by 31.29% to -$12.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$12.0 million, -$15.9 million, and -$9.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.